Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/885074/000110465919036025/a19-9098_110q.htm
November 2019
October 2019
March 2019
January 2019
January 2019
December 2018
December 2018
October 2018
September 2018
July 2018
Document And Entity Information - shares | 9 Months Ended | |
---|---|---|
Mar. 31, 2019 | Jun. 13, 2019 | |
Document Information [Line Items] | ||
Entity Registrant Name | AEON GLOBAL HEALTH CORP. | |
Entity Central Index Key | 0000885074 | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 9,915,064 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/885074/000110465919036025/a19-9098_110q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aeon Global Health Corp..
Aeon Global Health Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Aeon Global Health Corp. provided additional information to their SEC Filing as exhibits
Ticker: AGHC
CIK: 885074
Form Type: 10-Q Quarterly Report
Accession Number: 0001104659-19-036025
Submitted to the SEC: Mon Jun 17 2019 9:42:06 PM EST
Accepted by the SEC: Tue Jun 18 2019
Period: Sunday, March 31, 2019
Industry: Medical Laboratories